CIK: 0001538653 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $1,358,926 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CACC | CREDIT ACCEP CORP MICH | 1,552,428 | $728,803 | 53.6% | $107.75 | +330.3% | COM | 225310101 |
| CMPR | CIMPRESS PLC | 3,612,560 | $259,093 | 19.1% | $129.96 | -39.6% | SHS EURO | G2143T103 |
| WRLD | WORLD ACCEP CORP DEL | 2,037,495 | $229,096 | 16.9% | $81.92 | +42.5% | COM | 981419104 |
| W | WAYFAIR INC | 2,922,401 | $129,521 | 9.5% | $53.95 | -12.6% | CL A | 94419L101 |
| BTI | BRITISH AMERN TOB PLC | 220,100 | $7,994 | 0.6% | $31.45 | — | SPONSORED ADR | 110448107 |
| PM | PHILIP MORRIS INTL INC | 28,000 | $3,370 | 0.2% | $91.29 | +32.1% | COM | 718172109 |
| POWW | AMMO INC | 587,000 | $646 | 0.0% | $2.31 | -48.6% | COM | 00175J107 |
| TPB | TURNING PT BRANDS INC | 3,500 | $210 | 0.0% | $53.39 | 0.0% | COM | 90041L105 |
| LCTX | LINEAGE CELL THERAPEUTICS IN | 386,000 | $194 | 0.0% | $1.03 | -28.7% | COM | 53566P109 |